Research Grants: Grants-in-Aid of Research (GIA)

Grant Name
Research Grants: Grants-in-Aid of Research (GIA)
Funder
Crohn's and Colitis Canada
Country or Region
Canada
Research Field
Chronic Illnesses
Clinical Research or Studies
Digestive Diseases and Disorders
Disease
Disease Prevention
Gastroenterology
Health and Medicine
Health Care Planning or Policy
Inflammation
Inflammatory Bowel Disease
Internal Medicine
Medical Treatment
Patient Care and Education
Public Health
Specialties of Medical and Allied Fields
Deadline
November 22, 2021 (Expired)
Grant Size
Upper $375,000CAD Lower $5,000CAD Grants will be in the range of $5,000 to a maximum of $125,000 CDN per year. Funding is limited to a maximum of $125,000 per year, for up to three years. These funds may be used to pay technicians' and/or qualified students' salaries, purchase materials, supplies and items of equipment (costing less than $5,000 annually), to buy and maintain animals, and to support travel costs to a limit of $2,500 annually. Applicants within three years of their first faculty appointment at a Canadian institution may use up to $25,000 in Year One of the $125,000 maximum to purchase materials, supplies, and equipment needed for the startup of a new laboratory.
Contact Info
Research Grants Administrator research@crohnsandcolitis.ca
Eligibility
Investigators who hold an academic appointment at a Canadian University in a Faculty of Medicine, Nursing, Pharmacy, Veterinary Medicine or other Graduate Faculty are eligible to apply to as principal investigators for grant support of their research. Co-Investigators based outside of Canada are acceptable. If an applicant does not hold an academic appointment at the time of submitting an application, a cover letter from the Dean of the Faculty must be uploaded to the application, indicating the planned position and the date it will take effect. Investigators in Faculties other than the health sciences may also apply if the proposed research is deemed relevant to Crohn's and Colitis Canada's mission and strategic directions. Support for qualified undergraduate and graduate students within the operating budget is permissible. In order to be eligible to receive funding for a GIA from Crohn's and Colitis Canada, recipients must be members of the Crohn's and Colitis Canada IBD Research Institute. In any given year, a researcher may apply as a Principal Investigator on one GIA, and as a Co-Investigator on one other GIA grant application. Funding under other specific Crohn's and Colitis Canada programs (example: Innovations in IBD, GEM project, personnel award or Symposium) do not restrict eligibility for GIAs. Researchers must reside in Canada to apply for funding.
Description
The program supports research on inflammatory bowel disease (IBD). This research program helps advance prevention, treatments, health policy and, ultimately find cures. Grants support research projects with a defined objective, conducted by an investigator working alone or in collaboration with others. Eligibility Investigators who hold an academic appointment at a Canadian University in a Faculty of Medicine, Nursing, Pharmacy, Veterinary Medicine or other Graduate Faculty are eligible to apply to as principal investigators for grant support of their research. Co-Investigators based outside of Canada are acceptable. If an applicant does not hold an academic appointment at the time of submitting an application, a cover letter from the Dean of the Faculty must be uploaded to the application, indicating the planned position and the date it will take effect. Investigators in Faculties other than the health sciences may also apply if the proposed research is deemed relevant to Crohn's and Colitis Canada's mission and strategic directions. Support for qualified undergraduate and graduate students within the operating budget is permissible. In order to be eligible to receive funding for a GIA from Crohn's and Colitis Canada, recipients must be members of the Crohn's and Colitis Canada IBD Research Institute. In any given year, a researcher may apply as a Principal Investigator on one GIA, and as a Co-Investigator on one other GIA grant application. Funding under other specific Crohn's and Colitis Canada programs (example: Innovations in IBD, GEM project, personnel award or Symposium) do not restrict eligibility for GIAs. Researchers must reside in Canada to apply for funding.

Funding resources

Purdue Grant Writing Lab: Introduction to Grant Writing Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal Open Link

Quick share


Add deadline to calendar

November 22, 2021

Have a funding opportunity that you want to list here?

Submit the grant details to support@peeref.com for review and listing.


Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Related opportunities

NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
Health April 5, 2024 $1,000,000
Bio-printing of living cells for regenerative medicine
Digital Agenda 2024-04-11 €25000000
Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential
Viruses 2024-04-11 €50000000
Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators
Translational medicine 2024-04-11 €2000000
Saving Koalas Fund - Health Grants
Zoos, Wildlife Sanctuaries and Conservat... 12-Apr-2024 $19,900,000.00
Northern Territory Pathways to Community Control
Indigenous Health 30-Jun-2024 $8,750,000.00
Leading Engineering for America's Prosperity, Health, and Infrastructure
Science and Technology and other Researc... Sep 16, 2024 12:00:00 AM EDT $2,000,000
NIOSH Centers for Agricultural Safety and Health
Health Dec 01, 2024 12:00:00 AM EST $2,200,000
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
Innovative Health Practices
Science and Technology and other Researc... Feb 20, 2028 12:00:00 AM EST $1,000,000,000